Germline mutations in BRCA1 and BRCA2 among Brazilian women with ovarian cancer treated in the Public Health System

Germline mutations in BRCA1 and BRCA2 among Brazilian women with ovarian cancer treated in the Public Health System

Abstract Background Germline mutations in BRCA1 and BRCA2 genes are among the main causes of hereditary ovarian cancer. Identifying these mutations may reduce cancer risk, facilitate early detection, and enable personalized treatment. However, genetic testing is limited in the Brazilian Public Healt...

Full description

Bibliographic Details
Main Authors: Caroline de Oliveira Ferreira, Vandré Cabral Gomes Carneiro, Carolline Araujo Mariz
Format: Article
Language:English
Published: BMC 2024-04-01
Series:BMC Cancer
Subjects:
Brazil
BRCA1
BRCA2
Germline mutations
Ovary cancer
Online Access:https://doi.org/10.1186/s12885-024-12246-1

Internet

https://doi.org/10.1186/s12885-024-12246-1

Similar Items